Optimizerx Corporation logo

Optimizerx Corporation (OPRX)

Market Closed
17 Jul, 20:00
NASDAQ (CM) NASDAQ (CM)
$
6. 69
+0.04
+0.6015%
$
122.54M Market Cap
- P/E Ratio
- Div Yield
272,700 Volume
0.38 Eps
$ 6.65
Previous Close
Add Transaction
Day Range
6.51 6.72
Year Range
4.54 22.25
Want to track OPRX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

OPRX closed today higher at $6.69, an increase of 0.6015% from yesterday's close, completing a monthly increase of 28.6538% or $1.49. Over the past 12 months, OPRX stock lost -45.9612%.
OPRX is not paying dividends to its shareholders.
The last earnings report, released on May 11, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.0852%, based on the last three reports.
Optimizerx Corporation has completed 1 stock splits, with the recent split occurring on May 14, 2018.
The company's stock is traded on one exchange.

OPRX Chart

People also search for

Crexendo, Inc.
$ 7.66
-2.2959%
Troops Inc.
$ 2.28
+4.1096%
Velo3D, Inc.
$ 10.59
+2.3683%
Aeluma Inc.
$ 14.6
-3.5667%
Lantronix Inc.
$ 5.19
-4.0665%
OptimizeRx vs. Doximity: Which Digital Health Stock Is the Better Bet?

OptimizeRx vs. Doximity: Which Digital Health Stock Is the Better Bet?

OPRX and DOCS are betting big on AI-driven healthcare engagement as cautious pharma spending pressures near-term growth.

Zacks | 1 month ago
OptimizeRx Stock Down 30% in a Month: Should Investors Hold or Fold?

OptimizeRx Stock Down 30% in a Month: Should Investors Hold or Fold?

OPRX's shares slid 30% in a month as MFN pricing and cautious pharma spending hit revenue, even as DAAP growth and EBITDA surged.

Zacks | 1 month ago
OPRX Boosts DSP Revenue Potential While Navigating Near-Term Headwinds

OPRX Boosts DSP Revenue Potential While Navigating Near-Term Headwinds

OptimizeRx expands DSP integration to unlock scalable EHR ad campaigns and boost inventory use despite lowering 2026 revenue guidance.

Zacks | 1 month ago

Optimizerx Corporation Investors

Name Quantity Cost Value Profit ($) Gain (%)
CE
Curtis Ellergodt Rothschild Investment LLC
5 $61 $34.2 -$26.8 -43.93%
LJB
Laura J. Bornheimer GWN SECURITIES Inc.
54,850 $478,158.76 $372,431.5 -$105,727.26 -22.11%
Joseph Castro
Joseph Castro Nuveen LLC
38,998 $474,722.59 $262,179.65 -$212,542.94 -44.77%
Bobby Adusumilli
Bobby Adusumilli SJS Investment Consulting Inc.
44 $276.32 $296.56 $20.24 7.32%
Ana-Maria Ignat
Ana-Maria Ignat Covestor Ltd
1,914 $25,839 $12,823.8 -$13,015.2 -50.37%

Optimizerx Corporation (OPRX) FAQ

What is the stock price today?

The current price is $6.69.

On which exchange is it traded?

Optimizerx Corporation is listed on NASDAQ (CM).

What is its stock symbol?

The ticker symbol is OPRX.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 122.54M.

Has Optimizerx Corporation ever had a stock split?

Optimizerx Corporation had 1 splits and the recent split was on May 14, 2018.

Optimizerx Corporation Profile

Software Industry
Information Technology Sector
Stephen L. Silvestro CEO
NASDAQ (CM) Exchange
68401U204 CUSIP
US Country
133 Employees
- Last Dividend
14 May 2018 Last Split
22 Oct 1996 IPO Date

Overview

OptimizeRx Corporation is a pioneering digital health technology company, established in 2006 and headquartered in Waltham, Massachusetts. It specializes in facilitating communication between life sciences organizations, healthcare providers, and patients at various crucial points throughout the patient care journey. By leveraging its innovative technology, OptimizeRx Corporation aims to improve patient outcomes and support healthcare providers by delivering timely and relevant treatment information. The company's focus on care-focused engagement stands out in the healthcare technology sector, making it a key player in driving advancements in digital health care solutions.

Products and Services

  • Artificial Intelligence-generated Dynamic Audience and Activation Platform:

    This platform represents the core of OptimizeRx’s offerings. It employs artificial intelligence to generate dynamic audiences and enable the execution of both traditional and dynamic marketing campaigns. Traditional marketing campaigns can run on OptimizeRx’s proprietary digital point-of-care network, which includes healthcare providers and patients. The more innovative aspect, however, lies in its dynamic marketing campaigns. These campaigns adjust and optimize audiences in real time based on clinical care events, ensuring that healthcare professionals and patients receive the most relevant and timely treatment information. This real-time optimization enhances the effectiveness of communication between pharmaceutical companies, healthcare providers, and patients, ultimately aiming to improve patient care outcomes.

Contact Information

Address: 260 Charles Street
Phone: 248 651 6568